Lanean...
Impact of New Medications and $4 Generic Programs on Overactive Bladder Treatment among Older Adults in the United States, 2000–2015
BACKGROUND: Despite several new medications being FDA-approved for overactive bladder (OAB) and new prescription drug payment programs, there are limited population-based data regarding OAB medication use among older adults. OBJECTIVES: To examine (1) impacts of new medications and $4 generic progra...
Gorde:
| Argitaratua izan da: | Med Care |
|---|---|
| Egile Nagusiak: | , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2018
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5766403/ https://ncbi.nlm.nih.gov/pubmed/29287033 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MLR.0000000000000858 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|